1NWV
SOLUTION STRUCTURE OF A FUNCTIONALLY ACTIVE COMPONENT OF DECAY ACCELERATING FACTOR
1NWV の概要
| エントリーDOI | 10.2210/pdb1nwv/pdb |
| NMR情報 | BMRB: 5506 |
| 分子名称 | Complement decay-accelerating factor (1 entity in total) |
| 機能のキーワード | cd55, daf, ccp, complement, biosynthetic protein |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Cell membrane; Lipid-anchor, GPI- anchor: P08174 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 14351.30 |
| 構造登録者 | Uhrinova, S.,Lin, F.,Ball, G.,Bromek, K.,Uhrin, D.,Medof, M.E.,Barlow, P.N. (登録日: 2003-02-07, 公開日: 2003-04-22, 最終更新日: 2024-10-16) |
| 主引用文献 | Uhrinova, S.,Lin, F.,Ball, G.,Bromek, K.,Uhrin, D.,Medof, M.E.,Barlow, P.N. Solution structure of a functionally active fragment of decay-accelerating factor Proc.Natl.Acad.Sci.USA, 100:4718-4723, 2003 Cited by PubMed Abstract: The second and third modules of human decay accelerating factor (DAF) are necessary and sufficient to accelerate decay of the classical pathway (CP) convertase of complement. No structure of a mammalian protein with decay-accelerating activity has been available to date. We therefore determined the solution structure of DAF modules 2 and 3 (DAF approximately 2,3). Structure-guided analysis of 24 mutants identified likely contact points between DAF and the CP convertase. Three (R96, R69, and a residue in the vicinity of L171) lie on DAF approximately 2,3's concave face. A fourth, consisting of K127 and nearby R100, is on the opposite face. Regions of module 3 remote from the semiflexible 2-3 interface seem not to be involved in binding to the CP convertase. DAF thus seems to occupy a groove on the CP convertase such that both faces of DAF close to the 2-3 junction (including a positively charged region that encircles the protein at this point) interact simultaneously. Alternative pathway convertase interactions with DAF require additional regions of CCP 3 lying away from the 2-3 interface, consistent with the established additional requirement of module 4 for alternative pathway regulation. PubMed: 12672958DOI: 10.1073/pnas.0730844100 主引用文献が同じPDBエントリー |
| 実験手法 | SOLUTION NMR |
構造検証レポート
検証レポート(詳細版)
をダウンロード






